Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Cao

Showing results (281-290 of 616) with videos related to

Pageof 62
Sort By:
BMC Cancer|July 11, 2020
Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinomaLin Shui, Ke Cheng, Xiaofen Li, et al.
Healthcare (Basel, Switzerland)|May 13, 2023
Evaluating the Impact of COVID-19 on Hospital Profit Compensation Activities: A Difference-in-Differences Event Study Analysis in ChinaChi Shen, Dan Cao, Qiwei Deng, et al.
BMC Oral Health|April 3, 2023
Evaluating the accuracy of automated cephalometric analysis based on artificial intelligenceHan Bao, Kejia Zhang, Chenhao Yu, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|November 4, 2008
[Microclimate and comfortable degree of Shanghai urban open spaces in summer]Dan Cao, Li-chen Zhou, Yi-wei Mao, et al.
Journal of Ethnopharmacology|October 4, 2011
Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu)Dongyan Guo, Junzhi Wang, Xingqin Wang, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|October 14, 2016
Bone Marrow Urokinase Plasminogen Activator Receptor Levels are Associated with the Progress of Multiple MyelomaLi-Hong Shou, Dan Cao, Xiao-Hui Dong, et al.
Frontiers in Oncology|January 31, 2022
Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric CancerWanrui Lv, Ke Cheng, Xiaofen Li, et al.
Nature Communications|May 22, 2023
Functional specialization and interaction in the amygdala-hippocampus circuit during working memory processingJin Li, Dan Cao, Shan Yu, et al.
RSC Advances|February 23, 2023
Low-cost diatomite supported binary transition metal sulfates: an efficient reusable solid catalyst for biodiesel synthesisWeiqing Chen, Zhaoji Wu, Ruoxue Peng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2023
Friend or foe? The dual role of triptolide in the liver, kidney, and heartShiyuan Jiang, Feng Wan, Hui Lian, et al.
Pageof 62

Showing results (281-290 of 616) with videos related to

Sort By:
Pageof 62
BMC Cancer|July 11, 2020
Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinomaLin Shui, Ke Cheng, Xiaofen Li, et al.
Healthcare (Basel, Switzerland)|May 13, 2023
Evaluating the Impact of COVID-19 on Hospital Profit Compensation Activities: A Difference-in-Differences Event Study Analysis in ChinaChi Shen, Dan Cao, Qiwei Deng, et al.
BMC Oral Health|April 3, 2023
Evaluating the accuracy of automated cephalometric analysis based on artificial intelligenceHan Bao, Kejia Zhang, Chenhao Yu, et al.
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|November 4, 2008
[Microclimate and comfortable degree of Shanghai urban open spaces in summer]Dan Cao, Li-chen Zhou, Yi-wei Mao, et al.
Journal of Ethnopharmacology|October 4, 2011
Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu)Dongyan Guo, Junzhi Wang, Xingqin Wang, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|October 14, 2016
Bone Marrow Urokinase Plasminogen Activator Receptor Levels are Associated with the Progress of Multiple MyelomaLi-Hong Shou, Dan Cao, Xiao-Hui Dong, et al.
Frontiers in Oncology|January 31, 2022
Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein-Barr Virus-Associated Gastric CancerWanrui Lv, Ke Cheng, Xiaofen Li, et al.
Nature Communications|May 22, 2023
Functional specialization and interaction in the amygdala-hippocampus circuit during working memory processingJin Li, Dan Cao, Shan Yu, et al.
RSC Advances|February 23, 2023
Low-cost diatomite supported binary transition metal sulfates: an efficient reusable solid catalyst for biodiesel synthesisWeiqing Chen, Zhaoji Wu, Ruoxue Peng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2023
Friend or foe? The dual role of triptolide in the liver, kidney, and heartShiyuan Jiang, Feng Wan, Hui Lian, et al.
Pageof 62